PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas

Oncogene

Volumn 24, Issue 8, 2005, Pages 1477-1480

  Lee, Jong Woo ^a   Soung, Young Hwa ^a   Kim, Su Young ^a   Lee, Hae Woo ^a   Park, Won Sang ^a   Nam, Suk Woo ^a   Kim, Sang Ho ^a   Lee, Jung Young ^a   Yoo, Nam Jin ^a   Lee, Sug Hyung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cancer; Mutation; Oncogene; PIK3CA

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE CATALYTIC ALPHA; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ARTICLE; BREAST CARCINOMA; CANCER STAGING; COLON CANCER; GENE MUTATION; HUMAN; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; STOMACH CARCINOMA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CARCINOMA; CARCINOMA, HEPATOCELLULAR; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MUTATION;

EID: 20044388328     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208304     Document Type: Article

References (22)

1. Arteaga CL, Moulder SL and Yakes FM. (2002). Semin. Oncol., 29, 4-10.
2. Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G and Testa JR. (1995). Int. J. Cancer, 64, 280-285.
3. Benistant C, Chapuis H and Roche S. (2000). Oncogene, 19, 5083-5090.
4. Bogomoletz WV. (1984). Am. J. Surg. Pathol., 8, 381-391.
5. Cantley LC. (2002). Science, 296, 1655-1657.
6. Cantley LC and Neel BG. (1999). Proc. Natl. Acad. Sci. USA, 96, 4240-4245.
7. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R and Talpaz M. (2001). N. Engl. J. Med., 344, 1038-1042.
8. Edmondson HA and Steiner PE. (1954). Cancer, 7, 462-503.
9. International Working Party (1995). Hepatology, 22, 983-993.
10. Kim HS, Lee JW, Soung YH, Park WS, Kim SY, Lee JH, Park JY, Cho YG, Kim CJ, Jeong SW, Nam SW, Kim SH, Lee JY, Yoo NJ and Lee SH. (2003). Gastroenterology, 125, 708-715.
11. Lee JY, Dong SM, Kim SY, Yoo NJ, Lee SH and Park WS. (1998). Virchows Arch., 433, 305-309.
12. Luo J, Manning BD and Cantley LC. (2003). Cancer Cell, 4, 257-262.
13. Phillips WA, St Clair F, Munday AD, Thomas RJ and Mitchell CA. (1998). Cancer, 83, 41-47.
14. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B and Velculescu VE. (2004). Science, 304, 554.
15. Shay JW, Wright WE and Werbin H. (1993). Breast Cancer Res. Treat., 25, 83-94.
16. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB and Gray JW. (1999). Nat. Genet., 21, 99-102.
17. Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F and Hawkins PT. (1997). Science, 277, 567-570.
18. Ueki K, Algenstaedt P, Mauvais-Jarvis F and Kahn CR. (2000). Mol. Cell. Biol., 20, 8035-8046.
19. Vanhaesebroeck B and Alessi DR. (2000). Biochem. J., 346 (Part 3), 561-576.
20. Vivanco I and Sawyers CL. (2002). Nat. Rev. Cancer, 2, 489-501.
21. Wakeling AE, Guy SP, Woodburn JR, Ashton SE, Curry BJ, Barker AJ and Gibson KH. (2002). Cancer Res., 62, 5749-5754.
22. Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X, Jiang C, Coppola D, Nicosia SV and Cheng JQ. (2000). Oncogene, 19, 2324-2330.